David Mahvi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David Mahvi

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cancer Medicine|October 18, 2020

Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare systemAlexandria G Bauer, Melanie Jefferson, Georges J Nahhas, et al.

Cancer Immunology, Immunotherapy : CII|September 28, 2005

Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcomaBrian S Choi, Paul M Sondel, Jacquelyn A Hank, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patientsDavid M King, Mark R Albertini, Heidi Schalch, et al.

Cancer Immunology, Immunotherapy : CII|August 4, 2018

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanomaMark R Albertini, Richard K Yang, Erik A Ranheim, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cancer Medicine|October 18, 2020

Financial toxicity and strain among men receiving prostate cancer care in an equal access healthcare systemAlexandria G Bauer, Melanie Jefferson, Georges J Nahhas, et al.

Cancer Immunology, Immunotherapy : CII|September 28, 2005

Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcomaBrian S Choi, Paul M Sondel, Jacquelyn A Hank, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patientsDavid M King, Mark R Albertini, Heidi Schalch, et al.

Cancer Immunology, Immunotherapy : CII|August 4, 2018

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanomaMark R Albertini, Richard K Yang, Erik A Ranheim, et al.

Pageof 2